TechFlow news, June 5 — According to Globe Newswire, the board of directors of Nasdaq-listed biopharmaceutical company Silo Pharma (Nasdaq: SILO) has approved the purchase of up to $1 million worth of bitcoin as corporate treasury assets.
Silo Pharma CEO Eric Weisblum said that incorporating bitcoin into the company's treasury is a strategic decision aimed at diversifying assets through digital value storage and serving as a hedge against inflation. The company expects this move will help preserve and optimize long-term shareholder value.




